Ali Hussain, Z., Jafar, A., H. Al-Nakash, A. (2021). Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovary Syndrome. Alustath, 21(3), 326-332. doi: 10.52573/ipmj.2021.175814
Zahraa Mohammed Ali Hussain; Anwar Khazal Jafar; Abdul Razak H. Al-Nakash. "Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovary Syndrome". Alustath, 21, 3, 2021, 326-332. doi: 10.52573/ipmj.2021.175814
Ali Hussain, Z., Jafar, A., H. Al-Nakash, A. (2021). 'Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovary Syndrome', Alustath, 21(3), pp. 326-332. doi: 10.52573/ipmj.2021.175814
Ali Hussain, Z., Jafar, A., H. Al-Nakash, A. Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovary Syndrome. Alustath, 2021; 21(3): 326-332. doi: 10.52573/ipmj.2021.175814

Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovary Syndrome

Iraqi Postgraduate Medical Journal
Article 12, Volume 21, Issue 3, July 2022, Pages 326-332    PDF (217.85 K)
DOI: 10.52573/ipmj.2021.175814
Authors
Zahraa Mohammed Ali Hussain1; Anwar Khazal Jafar2; Abdul Razak H. Al-Nakash3
1Al-Elwiya Maternity Teaching Hospital Candidate of Arab Board for Obstetrics and Gynecology, Baghdad, Iraq
2Specialist in Obstetrics and Gynecology Al-Elwiya Maternity Teaching Hospital, Baghdad, Iraq
3Consultant in Obstetrics and Gynecology Akindy College of Medicine Al-Elwiya Maternity Teaching Hospital, Baghdad, Iraq
Abstract
BACKGROUND:
Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder characterized by multiple hormonal imbalances, reflecting on a clinical presentation dominated by manifestations of hyperandrogenism and insulin resistance. Plasma homocysteine is a non-protein sulfur-containing                α-amino acid plays a role in cardiovascular morbidity and mortality due to its atherogenic and prothrombotic properties.
OBJECTIVE:
To assess the association between insulin resistance and homocysteine level in women suffering from polycystic ovary syndrome.
Study design: A case control study.
Setting: Department of Obstetrics and Gynecology at Al-Elwiya Maternity Teaching Hospital during the period from 1st of March 2017 to end of April 2018.
MATERIALS AND METHOD:
One hundred women suffering from polycystic ovary syndrome and same number of healthy women were included in the study.
After assessment according to questioner form, fasting blood sugar, serum insulin and plasma homocysteine were checked to find the association among them, the insulin resistance was calculated according to the following formula “IR= Fasting Glucose X Fasting Insulin/22.5= mmol/dl”.
RESULTS:
Increase in body mass index is found to be accompanied with increase in mean fasting blood sugar (6.4±2.7 mmol/L), Insulin resistance (11.6±10.7 mmol/L) and homocystiene level (14.9±1.6 µmol/L) when compared to control group whose mean values are (4.4±0.5 mmol/L, 3.6±1.5 mmol/L and 9±1.7 µmol/L) respectively were significantly higher. A noticeable significant association between obesity and high fasting blood sugar (p0.04), high insulin resistance (p0.009) and homocysteine level (p0.001) in women suffering PCOS.
CONCLUSION:
There are significant differences found in homocysteine level and insulin resistance among women suffering from PCOS when compared to control group. A significant positive association between increased homocysteine level and insulin resistance with increased body mass index in women              with PCOS.
 
Keywords
PCOS; insulin resistance; homocysteine
References
  1. Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best practice & research clinical obstetrics & gynaecology. 2004;18:685-706.
  2. Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertility Society Journal. 2011;16:19-37.
  3. Isikoglu M, Berkkanoglu M, Cemal H, Ozgur K. Polycystic ovary syndrome: What is the role of obesity? In: Allahbadia GN, Agrawal R, editors. Polycystic Ovary Syndrome. Kent, UK: Anshan, Ltd. 2007;157–63.
  4. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Systemic Revision. 2011; 7.
  5. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. Journal of Clinical of Endocrinology Metabolism. 2006;91:336-40.
  6. Zhang C,Cai Y,Adachi MT,Oshiro S, Aso T. Homocysteine induce programmed cell death in human vascular endothelial cells through activation of the unfolded protein response .Journal of biological chemistry.2001;38:276
  7. Del Bianco A, Maruotti G, Fulgieri AM. Recurrent spontaneous miscarriages and hyperhomocysteinemia. Journal of Obstetric and Gynecology Reprod Biology.2014;56:379-83.
  8. Salehpour, S., Ozra Manzor-al-ajdad, M., Elham Neisani Samani, M. and Abadi, A. Evaluation of Homocysteine Levels in Patients with Polycystic Ovarian Syndrome. International Journal of Fertility & Sterility.2011;4:168-71.
  9. Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JC. Increased plasma homocysteine after menopause. Atherosclerosis. 2000;149:163-68.
  10. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O. Insulin Resistance in Patients with Polycystic Ovary Syndrome Is Associated with Elevated Plasma Homocysteine. Human Reproduction.2003;18:721-27. 
  11. Peppard HR, Marfori J, Iuorno MJ, Nestler JE. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care. 2001;24:1050–52.
  12. Sachan Rekha, M.L Patel,Gupta Pooja, Sachan Pushpalata, S.M. Natu,Y. Pradeep. Correlation of plasma homocysteine levels with BMI and insulin resistance, amongst obese, overweight and non-obese infertile women. International Journal of Scientific and Research Publications.2012; 2:1–6.
  13. Upadhye JJ, Shembekar CA. Awareness of PCOS (polycystic ovarian syndrome) in adolescent and young girls. International Journal of Reproduction, Contraception, Obstetrics and Gynecology.2017;6:2297-301.
  14. Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS. Endocrine. 2006 Aug 1;30:19-26.
  15. Pasquali R, Gambineri A. Insulin-sensitizing agents in polycystic ovary syndrome. Europian Journal of Endocrinology.2006;154: 763-75.
  16. Barnard, L., Ferriday, D., Guenther, N., Strauss, B., Balen, A. H., & Dye, L. Quality of life and psychological wellbeing in polycystic ovary syndrome. Human Reproduction.2007; 22: 2279-2286
  17. Ahmed Badawy , Omnia State , Soma  Sh.Abd El Gawad ,Omar Abd El Aziz . Plasma homocysteine and polycystic ovary syndrome:The missed link. European Journal of Obstetrics & Gynecology and Reproductive Biology.2007;68-72.
  18. Maleedhu P, Vijayabhascar M, Sharma S.S.B, Kodumur P, Devid V. Status of homocysteine in polycystic ovary syndrome. Journal of clinical and diagnostic researches. 2014;8: 31-33.    
  19. Kilic –Okman T, Guldiken S, Kucuk M. Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome. Journal of Endocrinology.2004;51:505-8.
  20. Sedigheh Esmaeilzaldeh ,Eisa Tahmasbpour ,Maryam Gholinezhad  Chari. HyperHomocysteinemia ,Insuline  resistance and body mass index in Iranian young women with polycystic ovary syndrome.2017; 22: 149-55.
  21. Yarali  H, Yildiz  A, Aybar  F, Kabakcak  G, Bukulmez  O. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. International Journal of Fertility & Sterility. 2001;76: 511-16.
 

Statistics
Article View: 78
PDF Download: 31


Journal Management System. Powered by ejournalplus.com